Dr. Dietmar Katinger, MBA
“Individual therapy and prophylaxis is a trendsetting concept. I am happy to be able to contribute to a team of specialists.”
Dietmar Katinger was studying biotechnology at the University of Life Sciences, Vienna. In his thesis he was working on the development of an influenza vaccine. He is CEO of Polymun Scientific Immunbiologische Forschung GmbH, a company is developing and manufacturing biopharmaceuticals. His experience in finance, human resources, marketing, research co-operations and quality management are of great value for the new company BS-Immun.